February 2012 Drug Update Information - Pharmacy Benefits ...

Cefaclor
Suspensionn
February
8, 2012
Products Affected - Description
Cefaclor Suspension 125 mg/5 mL, Ranbaxy
75 mL bottle (NDC 63304-0954-
-01)
Trazodone tablets, Mylan
50 mg, 100 count (NDC 00378-3471-01)
100 mg, 100 count (NDC 00378-3472-01)
100 mg, 1000 count (NDC 00378-3472-10)
Trazodone tablets, Qualitest
100 mg, 500 count (NDC 00603-6161-28)
100 mg, 1000 count (NDC 00603-6161-32)
Trazodone tablets, Teva
300 mg, 100 count (NDC 00555-0733-02)
Reason for the Shortage
Apotex states the shortage was due to an import ban on this product that was only recently
removed. Apotex relaunched trazodone tablets in September, 2011.
Mylan and Qualitest cannot provide a reason
for the shortage.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=681
Source: http://www.a
ashp.org
Nystatin
Oral Suspension
February
8, 2012
Products Affected - Description
Nystatin Oral Suspension, 100,000 units/mL, Qualitest
60 mL (NDC 00603-1481-49)
473 mL (NDC 00603-1481-58)
Nystatin Oral Suspension, 100,000 units/mL, Taro
60 mL (NDC 51672-4117-04)
473 mL (NDC 51672-4117-09)
Reason for the Shortage
Fougera and Actavis have discontinued nystatin oral suspension.
Qualitestt states the reason for the
shortage is a raw materials shortage.
Taro and
PAI could not provide a reason for the shortage.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=841
Source: http://www.a
ashp.org
Dextroamphetamine Tablets
February
8, 2012
Products Affected - Description
Dextroamphetamine
tablets, Teva
5 mg tablets, 100 count (NDC 00555-0952-02)
10 mg tablets, 100 count (NDC 00555-0953-
-02)
Reason for the Shortage
Teva has
dextroamphetamine tablets and all other amphetamine products on back order due to a
raw material shortage.
Teva is the sole manufacturer of dextroamphetamine tablets.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=853
Source: http://www.a
ashp.org
56